NASDAQ:SPRY | Profit Breakdown | ARS Pharmaceuticals, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$33.66M-$61.47M-$62.34M
2026-03-31$22.68M-$60.15M-$60.62M
2025-12-31$28.09M-$41.47M-$41.32M
2025-09-30$32.5M-$53.19M-$51.15M
2025-06-30$15.72M-$47.61M-$44.88M
2025-03-31$7.97M-$37.18M-$33.94M
2024-12-31$86.58M$47.2M$49.93M
2024-09-30$2.07M-$21.75M-$19.13M
2024-06-30$500,000.00-$15.34M-$12.52M
2024-03-31$0.00-$13.19M-$10.29M
2023-12-31$0.00-$10.23M-$7.17M
2023-09-30$0.00-$17.98M-$14.87M
2023-06-30$10,000.00-$20.6M-$17.37M
2023-03-31$20,000.00-$18.71M-$14.96M
2022-12-31$0.00-$15.44M-$14.43M
2022-09-30$189,000.00-$6.63M-$6.58M
2022-06-30$464,000.00-$6.34M-$6.42M
2022-03-31$663,000.00-$7.1M-$7.25M
2021-12-31$46.62M$45.78M
2021-09-30-$22.68M-$22.66M
2021-06-30-$24.51M-$24.5M
2021-03-31-$18.89M-$18.87M
2020-12-31-$13.1M-$13.09M
2020-09-30-$8.11M-$8.12M
2020-06-30-$6.46M-$6.47M
2020-03-31-$5.24M-$5.28M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$84.28M-$179.45M-$171.38M-$171.3M
2024-12-31$89.15M-$3.08M$8.29M$8M
2023-12-31$30,000.00-$67.52M-$54.37M-$54.37M
2022-12-31$1.32M-$35.52M-$34.68M
2021-12-31$5.51M-$19.45M-$20.24M
2020-12-31-$32.92M-$32.95M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.